Toripalimab Recruiting Phase 2 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04169672Study of Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors